Education
About Us
Working with TipRanks
Follow Us
Vita Life Sciences Limited (AU:VLS)
ASX:VLS
Total Valuation
Vita Life Sciences Limited has a market cap or net worth of AU$133.59M. The enterprise value is AU$106.63M.
Market CapAU$133.59M
Enterprise ValueAU$106.63M
Share Statistics
Vita Life Sciences Limited has 54,973,263 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding54,973,263
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vita Life Sciences Limited’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 15.30%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)15.30%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover1.11
Inventory Turnover1.94
Valuation Ratios
The current PE Ratio of Vita Life Sciences Limited is 14.7. Vita Life Sciences Limited’s PEG ratio is ―.
PE Ratio14.7
PS Ratio―
PB Ratio―
Price to Fair Value2.10
Price to FCF―
Price to Operating Cash Flow21.16
PEG Ratio―
Income Statement
In the last 12 months, Vita Life Sciences Limited had revenue of 79.50M and earned 8.78M in profits. Earnings per share was 0.16.
Revenue79.50M
Gross Profit47.24M
Operating Income11.66M
Pretax Income12.64M
Net Income8.78M
EBITDA13.46M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 6.16M and capital expenditures -198.00K, giving a free cash flow of 5.96M billion.
Operating Cash Flow6.16M
Free Cash Flow5.96M
Free Cash Flow per Share0.11
Dividends & Yields
Vita Life Sciences Limited pays an annual dividend of AU$0.045, resulting in a dividend yield of 4.53%
Dividend Per ShareAU$0.045
Dividend Yield4.53%
Payout Ratio66.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change15.17%
50-Day Moving Average2.30
200-Day Moving Average1.99
Relative Strength Index (RSI)53.47
Average Volume (3m)11.00K
Important Dates
Vita Life Sciences Limited upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateAug 24, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend DateSep 19, 2025
Financial Position
Vita Life Sciences Limited as a current ratio of 3.06, with Debt / Equity ratio of 0.99%
Current Ratio3.06
Quick Ratio2.19
Debt to Market Cap0.00
Net Debt to EBITDA-2.09
Interest Coverage Ratio55.77
Taxes
In the past 12 months, Vita Life Sciences Limited has paid 3.86M in taxes.
Income Tax3.86M
Effective Tax Rate0.31
Enterprise Valuation
Vita Life Sciences Limited EV to EBITDA ratio is 6.09, with an EV/FCF ratio of 13.75.
EV to Sales1.03
EV to EBITDA6.09
EV to Free Cash Flow13.75
EV to Operating Cash Flow13.31
Balance Sheet
Vita Life Sciences Limited has AU$28.60M in cash and marketable securities with AU$517.00K in debt, giving a net cash position of AU$28.08M billion.
Cash & Marketable SecuritiesAU$28.60M
Total DebtAU$517.00K
Net CashAU$28.08M
Net Cash Per ShareAU$0.51
Tangible Book Value Per ShareAU$0.95
Margins
Gross margin is 59.42%, with operating margin of 14.66%, and net profit margin of 11.05%.
Gross Margin59.42%
Operating Margin14.66%
Pretax Margin15.90%
Net Profit Margin11.05%
EBITDA Margin16.93%
EBIT Margin16.16%
Analyst Forecast
The average price target for Vita Life Sciences Limited is AU$2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$2.50
Price Target Upside2.88% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast8.46%
EPS Growth Forecast-1.95%